R. Pasqualini et al., Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis, CANCER RES, 60(3), 2000, pp. 722-727
Phage that display a surface peptide with the NGR sequence motif home selec
tively to tumor vasculature in vivo. A drug coupled to an NGR peptide has m
ore potent antitumor effects than the free drug [W. Arap et at, Science CV(
Washington DC), 279: 377-380, 1998], We show here that the receptor for the
NGR peptides in tumor vasculature is aminopeptidase N (APN; also called CD
13). NGR phage specifically bound to immunocaptured APN and to cells engine
ered to express APN on their surface. Antibodies against APN inhibited in v
ivo tumor homing by the NGR phage. Immunohistochemical staining showed that
APN expression is up-regulated in endothelial cells within mouse and human
tumors. In another tissue that undergoes angiogenesis, corpus luteum, bloo
d vessels also expressed APN, but APN was not detected in blood vessels of
various other normal tissues stained under the same conditions. APN antagon
ists specifically inhibited angiogenesis in chorioallantoic membranes and i
n the retina and suppressed tumor growth. Thus, APN is involved in angiogen
esis and can serve as a target for delivering drugs into tumors and for inh
ibiting angiogenesis.